We use cookies to enhance the usability of our website. If you continue, we'll assume that you are happy to receive all cookies. More information. Don't show this again.
Fields »
 

Field

Term
Gene name

Class

Subclass

Chromosome

External id

In atlas

Reliability

Reliability

Reliability

Validation

Method

Validation

Method

Validation

Method

Validation

Location

Searches

Tissue

Cell type

Expression

Tissue

Specificity

Cell line

Specificity

Cancer

Specificity

Tissue

Detectable

Cell line

Detectable

Cancer

Detectable

Cancer

Prognosis

Category

Score

Score

Score

Antibodies

Column

 
 
ABOUT
HELP
BLOG
  • THE HUMAN PROTEOME
  • THE HUMAN TISSUES
  • THE HUMAN CELL
  • HUMAN PATHOLOGY
  • PROTEIN CLASSES
  • PROTEIN EVIDENCE
    • NEWS
    • BLOG
    • EVENTS
    • PRESS ROOM
    • LEARN
    • DICTIONARY
    • METHODS
    • CELL LINES
  • THE PROJECT
  • INTRODUCTION
  • ORGANIZATION
  • PUBLICATIONS
  • PUBLICATION DATA
  • ANTIBODY SUBMISSION
  • ANTIBODY AVAILABILITY
  • LINKS
  • CONTACT
  • TECHNICAL DATA
  • ANTIBODY VALIDATION
  • ASSAYS & ANNOTATION
  • DISCLAIMER
  • DOWNLOADABLE DATA
  • HELP & FAQ
  • LICENCE & CITATION
  • PRIVACY STATEMENT
  • RELEASE HISTORY
AOC3
  • premium

    TISSUE

  • CELL

  • PATHOLOGY

PATHOLOGY ATLAS

GENE/PROTEIN

Antibody validation

Dictionary

Level of antibody staining/expression





High
Medium
Low
Not detected

GENERAL INFORMATION

Gene name

AOC3

Gene description

Amine oxidase, copper containing 3

Protein class

Cancer-related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted secreted proteins

Predicted localization

Intracellular,Secreted

Number of transcripts

6
SHOW MORE

HUMAN PROTEIN ATLAS INFORMATION

RNA category

TCGA (cancer tissue):Expressed in all
HPA (cell line):Cell line enhanced (Hep G2)
HPA (normal tissue):Tissue enhanced (adipose tissue)

Protein evidence

Evidence at protein level

Protein expression
normal tissue

Selective cytoplasmic staining in smooth muscle, adipocytes, adrenal gland and alveolar cells.

ANTIBODY IHC RELIABILITY

Data reliability
description

Antibody staining consistent with RNA expression data. Antibody staining in cells/structures not annotated, view images.

Reliability score

Supported based on 2 antibodies.
HPA000980 , CAB025797
SHOW MORE

PROGNOSTIC SUMMARY

Prognostic marker in renal cancer (unfavourable), colorectal cancer (unfavourable) and urothelial cancer (unfavourable).
Renal cancer p<0.001
Colorectal cancer p<0.001
Urothelial cancer p<0.001
Show all

RNA EXPRESSION OVERVIEW

TCGA dataset
RNA cancer category: Expressed in all

PROTEIN EXPRESSION

Colorectal cancer
Breast cancer
Prostate cancer
Lung cancer
Liver cancer

STAINING SUMMARY

HPA000980
CAB025797

Cancer

Cancer staining

Protein
expression of
normal tissue

Breast cancer
 
Carcinoid
 
Cervical cancer
 
Colorectal cancer
 
 
Endometrial cancer
 
 
Glioma
 
Head and neck cancer
 
 
Liver cancer
 
 
Lung cancer
 
 
Lymphoma
 
 
 

Cancer

Cancer staining

Protein
expression of
normal tissue

Melanoma
 
Ovarian cancer
 
Pancreatic cancer
 
Prostate cancer
 
Renal cancer
 
Skin cancer
 
Stomach cancer
 
 
Testis cancer
 
Thyroid cancer
 
Urothelial cancer
 

Staining summary

Several prostate and endometrial cancers exhibited weak to moderate granular cytoplasmic immunoreactivity. The remaining malignant tissues were negative.

Cancer

Cancer staining

Protein
expression of
normal tissue

Breast cancer
 
Carcinoid
 
Cervical cancer
 
Colorectal cancer
 
 
Endometrial cancer
 
 
Glioma
 
Head and neck cancer
 
 
Liver cancer
 
 
Lung cancer
 
 
Lymphoma
 
 
 

Cancer

Cancer staining

Protein
expression of
normal tissue

Melanoma
 
Ovarian cancer
 
Pancreatic cancer
 
Prostate cancer
 
Renal cancer
 
Skin cancer
 
Stomach cancer
 
 
Testis cancer
 
Thyroid cancer
 
Urothelial cancer
 

Staining summary

Most malignant tissues were negative.

GENE INFORMATION

Gene name

AOC3 (HGNC Symbol)

Synonyms

HPAO, VAP-1, VAP1

Description

Amine oxidase, copper containing 3 (HGNC Symbol)

Entrez gene summary

This gene encodes a member of the semicarbazide-sensitive amine oxidase family. Copper amine oxidases catalyze the oxidative conversion of amines to aldehydes in the presence of copper and quinone cofactor. The encoded protein is localized to the cell surface, has adhesive properties as well as monoamine oxidase activity, and may be involved in leukocyte trafficking. Alterations in levels of the encoded protein may be associated with many diseases, including diabetes mellitus. A pseudogene of this gene has been described and is located approximately 9-kb downstream on the same chromosome. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Apr 2013]

Chromosome

17

Cytoband

q21.31

Chromosome location (bp)

42851184 - 42858130

Protein evidence

Evidence at protein level (all genes)

Ensembl

ENSG00000131471 (version 83.38)

Entrez gene

8639

UniProt

Q16853 (UniProt - Evidence at protein level)

neXtProt

NX_Q16853

Antibodypedia

AOC3 antibodies

PROTEIN BROWSER

AOC3-001
AOC3-002
AOC3-004
AOC3-005
AOC3-201
AOC3-202

PROTEIN INFORMATION

Splice variant

UniProt

Protein class

Gene ontology

Length & mass

Signal peptide
(predicted)

Transmembrane regions
(predicted)

AOC3-001
ENSP00000312326
ENST00000308423
Q16853 [Direct mapping]
Membrane primary amine oxidase
Show all
Enzymes
   ENZYME proteins
   Oxidoreductases
   MEMSAT3 predicted membrane proteins
   MEMSAT-SVM predicted membrane proteins
   THUMBUP predicted membrane proteins
   TMHMM predicted membrane proteins
Predicted secreted proteins
   Secreted proteins predicted by MDSEC
   Phobius predicted secreted proteins
   SPOCTOPUS predicted secreted proteins
Plasma proteins
Cancer-related genes
   Candidate cancer biomarkers
FDA approved drug targets
   Small molecule drugs
Protein evidence (Kim et al 2014)
Protein evidence (Ezkurdia et al 2014)
Show all
GO:0005261 [cation channel activity]
GO:0005507 [copper ion binding]
GO:0005509 [calcium ion binding]
GO:0005515 [protein binding]
GO:0005737 [cytoplasm]
GO:0005769 [early endosome]
GO:0005783 [endoplasmic reticulum]
GO:0005794 [Golgi apparatus]
GO:0005886 [plasma membrane]
GO:0005902 [microvillus]
GO:0006805 [xenobiotic metabolic process]
GO:0006954 [inflammatory response]
GO:0007155 [cell adhesion]
GO:0008131 [primary amine oxidase activity]
GO:0009308 [amine metabolic process]
GO:0009986 [cell surface]
GO:0016021 [integral component of membrane]
GO:0042803 [protein homodimerization activity]
GO:0044281 [small molecule metabolic process]
GO:0046677 [response to antibiotic]
GO:0046982 [protein heterodimerization activity]
GO:0048038 [quinone binding]
GO:0052593 [tryptamine:oxygen oxidoreductase (deaminating) activity]
GO:0052594 [aminoacetone:oxygen oxidoreductase(deaminating) activity]
GO:0052595 [aliphatic-amine oxidase activity]
GO:0052596 [phenethylamine:oxygen oxidoreductase (deaminating) activity]
GO:0055114 [oxidation-reduction process]
GO:0098655 [cation transmembrane transport]
Show all
763 aa
84.6 kDa
Yes 0
AOC3-002
ENSP00000468632
ENST00000591562
Q16853 [Direct mapping]
Membrane primary amine oxidase
Show all
Enzymes
   ENZYME proteins
   Oxidoreductases
Predicted intracellular proteins
Plasma proteins
Cancer-related genes
   Candidate cancer biomarkers
FDA approved drug targets
   Small molecule drugs
Protein evidence (Ezkurdia et al 2014)
Show all
GO:0005261 [cation channel activity]
GO:0005507 [copper ion binding]
GO:0005509 [calcium ion binding]
GO:0005515 [protein binding]
GO:0005737 [cytoplasm]
GO:0005769 [early endosome]
GO:0005783 [endoplasmic reticulum]
GO:0005794 [Golgi apparatus]
GO:0005886 [plasma membrane]
GO:0005902 [microvillus]
GO:0006805 [xenobiotic metabolic process]
GO:0006954 [inflammatory response]
GO:0007155 [cell adhesion]
GO:0008131 [primary amine oxidase activity]
GO:0009308 [amine metabolic process]
GO:0009986 [cell surface]
GO:0016021 [integral component of membrane]
GO:0042803 [protein homodimerization activity]
GO:0044281 [small molecule metabolic process]
GO:0046677 [response to antibiotic]
GO:0046982 [protein heterodimerization activity]
GO:0048038 [quinone binding]
GO:0052593 [tryptamine:oxygen oxidoreductase (deaminating) activity]
GO:0052594 [aminoacetone:oxygen oxidoreductase(deaminating) activity]
GO:0052595 [aliphatic-amine oxidase activity]
GO:0052596 [phenethylamine:oxygen oxidoreductase (deaminating) activity]
GO:0055114 [oxidation-reduction process]
GO:0098655 [cation transmembrane transport]
Show all
220 aa
24.5 kDa
No 0
AOC3-004
ENSP00000465913
ENST00000592999
K7EL47 [Direct mapping]
Membrane primary amine oxidase
Show all
Predicted intracellular proteins
Protein evidence (Ezkurdia et al 2014)
Show all
GO:0005507 [copper ion binding]
GO:0008131 [primary amine oxidase activity]
GO:0009308 [amine metabolic process]
GO:0048038 [quinone binding]
GO:0055114 [oxidation-reduction process]
Show all
152 aa
17.3 kDa
No 0
AOC3-005
ENSP00000468043
ENST00000588033
K7EQZ5 [Direct mapping]
Membrane primary amine oxidase
Show all
Predicted intracellular proteins
Protein evidence (Ezkurdia et al 2014)
Show all
GO:0005507 [copper ion binding]
GO:0008131 [primary amine oxidase activity]
GO:0009308 [amine metabolic process]
GO:0048038 [quinone binding]
GO:0055114 [oxidation-reduction process]
Show all
112 aa
12.9 kDa
No 0
AOC3-201
ENSP00000484312
ENST00000613571
Q16853 [Direct mapping]
Membrane primary amine oxidase
Show all
Enzymes
   ENZYME proteins
   Oxidoreductases
   MEMSAT3 predicted membrane proteins
   MEMSAT-SVM predicted membrane proteins
   THUMBUP predicted membrane proteins
   TMHMM predicted membrane proteins
Predicted secreted proteins
   Secreted proteins predicted by MDSEC
   Phobius predicted secreted proteins
   SPOCTOPUS predicted secreted proteins
Plasma proteins
Cancer-related genes
   Candidate cancer biomarkers
FDA approved drug targets
   Small molecule drugs
Protein evidence (Ezkurdia et al 2014)
Show all
GO:0005261 [cation channel activity]
GO:0005507 [copper ion binding]
GO:0005509 [calcium ion binding]
GO:0005515 [protein binding]
GO:0005737 [cytoplasm]
GO:0005769 [early endosome]
GO:0005783 [endoplasmic reticulum]
GO:0005794 [Golgi apparatus]
GO:0005886 [plasma membrane]
GO:0005902 [microvillus]
GO:0006805 [xenobiotic metabolic process]
GO:0006954 [inflammatory response]
GO:0007155 [cell adhesion]
GO:0008131 [primary amine oxidase activity]
GO:0009308 [amine metabolic process]
GO:0009986 [cell surface]
GO:0016021 [integral component of membrane]
GO:0042803 [protein homodimerization activity]
GO:0044281 [small molecule metabolic process]
GO:0046677 [response to antibiotic]
GO:0046982 [protein heterodimerization activity]
GO:0048038 [quinone binding]
GO:0052593 [tryptamine:oxygen oxidoreductase (deaminating) activity]
GO:0052594 [aminoacetone:oxygen oxidoreductase(deaminating) activity]
GO:0052595 [aliphatic-amine oxidase activity]
GO:0052596 [phenethylamine:oxygen oxidoreductase (deaminating) activity]
GO:0055114 [oxidation-reduction process]
GO:0098655 [cation transmembrane transport]
Show all
634 aa
70.7 kDa
Yes 0
AOC3-202
ENSP00000477686
ENST00000617500
Q16853 [Direct mapping]
Membrane primary amine oxidase
Show all
Enzymes
   ENZYME proteins
   Oxidoreductases
Predicted intracellular proteins
Plasma proteins
Cancer-related genes
   Candidate cancer biomarkers
FDA approved drug targets
   Small molecule drugs
Protein evidence (Ezkurdia et al 2014)
Show all
GO:0005261 [cation channel activity]
GO:0005507 [copper ion binding]
GO:0005509 [calcium ion binding]
GO:0005515 [protein binding]
GO:0005737 [cytoplasm]
GO:0005769 [early endosome]
GO:0005783 [endoplasmic reticulum]
GO:0005794 [Golgi apparatus]
GO:0005886 [plasma membrane]
GO:0005902 [microvillus]
GO:0006805 [xenobiotic metabolic process]
GO:0006954 [inflammatory response]
GO:0007155 [cell adhesion]
GO:0008131 [primary amine oxidase activity]
GO:0009308 [amine metabolic process]
GO:0009986 [cell surface]
GO:0016021 [integral component of membrane]
GO:0042803 [protein homodimerization activity]
GO:0044281 [small molecule metabolic process]
GO:0046677 [response to antibiotic]
GO:0046982 [protein heterodimerization activity]
GO:0048038 [quinone binding]
GO:0052593 [tryptamine:oxygen oxidoreductase (deaminating) activity]
GO:0052594 [aminoacetone:oxygen oxidoreductase(deaminating) activity]
GO:0052595 [aliphatic-amine oxidase activity]
GO:0052596 [phenethylamine:oxygen oxidoreductase (deaminating) activity]
GO:0055114 [oxidation-reduction process]
GO:0098655 [cation transmembrane transport]
Show all
220 aa
24.5 kDa
No 0

Contact

  • BLOG
  • PRESS ROOM
  • contact@proteinatlas.org

The Project

  • INTRODUCTION
  • ORGANIZATION
  • PUBLICATIONS
  • DOWNLOADABLE DATA

The Human Protein Atlas

  • ANTIBODY AVAILABILITY
  • LICENCE & CITATION
  • HELP & FAQ
The Human Protein Atlas project is funded
by the Knut & Alice Wallenberg foundation.